Viatris Confirms Delay On ‘First And Only’ Botox Biosimilar

Problems For Partner Revance’s Lead Pipeline Candidate Has ‘Direct Impact’

Delay Blocks Black White
Both parties commented on the delay to the program • Source: syahrir maulana / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products